However, a majority of inflammatory infiltrates in tumor show exhausted phenotype with expression of genes involved in Wnt/TGF-β signaling and M2 macrophage [39,40,44,45], and additional agents that alter the immune milieu should be required for the treatment of this subclass. The gene discussed is TGFB1; the disease is neoplasm.